Barclays’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,801
Closed -$196K 5488
2020
Q1
$196K Sell
1,801
-11,870
-87% -$2.12M ﹤0.01% 4308
2019
Q4
$3.54M Buy
13,671
+7,363
+117% +$2.75M ﹤0.01% 2382
2019
Q3
$3.32M Buy
6,308
+2,867
+83% +$2.12M ﹤0.01% 2278
2019
Q2
$3.24M Buy
3,441
+1,358
+65% +$1.36M ﹤0.01% 2341
2019
Q1
$2.27M Buy
+2,083
New +$1.86M ﹤0.01% 2433

Other funds holding ACB

Barclays's ACB Position: Q1 2026 in Review

Barclays reduced its Aurora Cannabis (ACB) stake by 18% in Q1 2026, selling an estimated $22.6K and leaving 27,717 shares worth $90.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4068.

Barclays first reported a position in ACB in Q4 2018 and has held it in 23 quarters since. The position peaked at $3.12M in Q2 2019. 155 funds tracked by Wall St. Rank hold ACB as of Q1 2026.

  • Barclays held 27,717 shares of Aurora Cannabis worth $90.6K as of Q1 2026.
  • Barclays sold 5,992 Aurora Cannabis shares in Q1 2026, an estimated $22.6K.
  • Aurora Cannabis made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4068 holding.
  • Barclays first reported a position in Aurora Cannabis in Q4 2018 and has held it in 23 quarters since.
  • Barclays's Aurora Cannabis position peaked at $3.12M in Q2 2019.
  • 155 funds tracked by Wall St. Rank held Aurora Cannabis as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.